|
Somia, N V; Schmitt, M J; Vetter, D E et al. (1999) LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc Natl Acad Sci U S A 96:12667-72
|
|
Miyoshi, H; Smith, K A; Mosier, D E et al. (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682-6
|
|
Wisdon, R; Verma, I M (1993) Transformation by Fos proteins requires a C-terminal transactivation domain. Mol Cell Biol 13:7429-38
|
|
Wisdom, R; Verma, I M (1993) Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation. Mol Cell Biol 13:2635-43
|
|
Link, E; Kerr, L D; Schreck, R et al. (1992) Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem 267:239-46
|
|
Roman, M; Axelrod, J H; Dai, Y et al. (1992) Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat Cell Mol Genet 18:247-58
|
|
Miyanohara, A; Johnson, P A; Elam, R L et al. (1992) Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. New Biol 4:238-46
|
|
Wisdom, R; Yen, J; Rashid, D et al. (1992) Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev 6:667-75
|
|
Bull, P; Morley, K L; Hoekstra, M F et al. (1990) The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol Cell Biol 10:5473-85
|
